Medical device outsourced manufacturing

What is Integer Holdings?

Integer Holdings is a medical device outsourced manufacturing company serving providers, payers, patients, labs, hospitals, researchers, or life-sciences commercial teams.

Category
Medical device outsourced manufacturing
Headquarters
Plano, TX
Founded
See company profile and filings
Employees
Mid-market / scaled operating company
Total funding
Public company
Status
Public company; NYSE: ITGR

What is Integer Holdings?

Integer Holdings is a medical device outsourced manufacturing company headquartered in Plano, TX.

Integer Holdings operates in medical device outsourced manufacturing and has reached a scaled mid-market profile rather than an early startup footprint. Its official site and investor/company materials position the business around Cardio and vascular components, Neuromodulation, Portable medical, with customers using the company for repeatable operating workflows rather than one-off projects.

For sellers, Integer Holdings is useful to profile because the buying center is large enough to include specialized finance, IT, operations, procurement, and line-of-business owners. The company status is Public company; NYSE: ITGR, so the best live signals are current company announcements, investor materials where available, hiring patterns, product launches, and partner ecosystem activity.

What does Integer Holdings offer?

Integer Holdings's profile centers on Cardio and vascular components, Neuromodulation, Portable medical, Batteries.

  • Cardio and vascular components· Medical device outsourced manufacturing
  • Neuromodulation· Medical device outsourced manufacturing
  • Portable medical· Medical device outsourced manufacturing
  • Batteries· Medical device outsourced manufacturing
  • Catheters· Medical device outsourced manufacturing
  • Manufacturing services· Medical device outsourced manufacturing

How does Integer Holdings make money?

Integer Holdings makes money through commercial activity tied to medical device outsourced manufacturing.

Integer Holdings monetizes through the commercial model common to medical device outsourced manufacturing: a mix of product sales, subscriptions, usage, services, channel programs, or transaction volume depending on the operating unit. Public list pricing is not always available, so enterprise buyers usually evaluate packaging, contract scope, geographic coverage, implementation services, and support commitments.

The practical growth levers are account expansion, new product attach, channel reach, retention, and operational efficiency. For outbound teams, that means relevant sales angles usually connect to productivity, integration, compliance, data quality, margin improvement, customer experience, or faster execution across distributed teams.

Who leads Integer Holdings?

Integer Holdings's named executives should be verified on the official leadership or investor-relations page before outreach.

  • Integer Holdings executive leadershipExecutive leadership teamCurrent as of June 2026Use the official leadership, governance, or investor-relations page for current named executives before outreach.
  • Integer Holdings finance leadershipFinance / CFO organizationCurrent as of June 2026Often owns investor communication, procurement governance, and budget discipline.
  • Integer Holdings technology or operations leadershipTechnology, product, operations, or security leadershipCurrent as of June 2026Likely stakeholder group for software, infrastructure, data, workflow, and operational-improvement purchases.

How do you contact Integer Holdings's leadership?

Integer Holdings should be contacted through official investor, media, partner, support, or sales routes unless a named executive publishes a direct address.

Email formatcontact via https://www.integer.net

How is Integer Holdings funded?

Integer Holdings's current status is Public company; NYSE: ITGR.

Integer Holdings's current capital profile is best understood through its current status: Public company; NYSE: ITGR. If the company is public, the relevant financing signals are annual reports, quarterly results, debt disclosures, buybacks, acquisitions, and capital allocation commentary rather than venture rounds.

If the company is private or recently acquired, the important seller signal is ownership context: sponsors or strategic owners often push standardization, operating metrics, procurement discipline, and integration work. In either case, budget timing should be inferred from current company announcements, earnings materials, product launches, hiring, and strategic initiatives rather than stale funding databases.

How did Integer Holdings get here?

Integer Holdings's history should be read through founding, scale-up, public/private ownership, and current product or market focus.

  1. FoundingInteger Holdings is foundedThe company begins building in medical device outsourced manufacturing.
  2. Scale-upCommercial footprint expandsInteger Holdings broadens its product, customer, or geographic reach.
  3. Capital marketsPublic company; NYSE: ITGROwnership and financing context shapes procurement, reporting, and operating priorities.
  4. 2025Mid-market operating profileThe company operates with specialized teams and repeatable buying centers.
  5. June 2026Current profile refreshedProfile generated from official domain, current status, and public source references.

Who are Integer Holdings's competitors?

Integer Holdings competes with larger platform incumbents and focused specialists in medical device outsourced manufacturing.

  • MedtronicGlobal medical-technology incumbent with broad device and care-management scale.
  • Boston ScientificLarge medical-device company competing across interventional specialties.
  • AbbottHealthcare company with diagnostics, diabetes care, devices, and nutrition scale.
  • Johnson & Johnson MedTechLarge medtech and pharmaceutical incumbent with global commercial reach.
  • StrykerOrthopedics, neurotechnology, and surgical equipment competitor with hospital relationships.

Integer Holdings — frequently asked questions

Agent CTA Background

Revenue work. On autopilot.

Start Free TrialBuilt for revenue teams who care about quality.